Fulgent Genetics
From Verify.Wiki
 | |
| | |
| Fulgent Genetics | |
|---|---|
| Type | Public |
| Industry | Biotechnology |
| Founded | 2011 |
| Headquarters | Temple City, California 91780 United States |
| Key people | Ming Hsieh (CEO), Han Lin Gao ( Chief Scientific Officer), Paul Kim (CFO) Cite error: Closing </ref> missing for <ref> tag
|
Fulgent Therapeutics, LLC is a pharmaceutical company focusing on developing and commercializing innovative cancer therapeutics. It focuses on providing genetic testing services to physicians with clinically actionable diagnostic information. It intends to provide tests to hospitals and medical institutions. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016.
They have Accreditations from the following:
- Clinical Laboratory Improvement Amendments (CLIA) License 2015-2017
- College of American Pathologists (CAP) Accreditation 2017
- California Clinical Laboratory License 2016
- Florida Clinical Laboratory License 2016 - 2018
- Pennsylvania Clinical Laboratory Permit 2016-2017
- Maryland Medical Laboratory License 2015-2016
Contents
History
Controversies
Top 5 Recent Tweets
| Date | Author | Comment |
|---|---|---|
| June 17, 2018 | ledgerzette | Brokerages Anticipate Fulgent Genetics Inc $FLGT to Announce -$0.05 EPS https://t.co/2LKlijUkhI |
| June 17, 2018 | AmericanBanking | Brokerages Anticipate Fulgent Genetics Inc $FLGT to Announce -$0.05 EPS https://t.co/Fz5uvoqjK4 #stocks |
Top 5 Recent News Headlines
Top 5 Lifetime Tweets
Top 5 Lifetime News Headlines
Top Authors
Verification history
595 days ago- View all verifications
